<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.0 20120330//EN" "JATS-journalpublishing1.dtd">
<article article-type="abstract" dtd-version="1.0" xml:lang="en" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">CC</journal-id>
<journal-id journal-id-type="nlm-ta">Cardiol Croat</journal-id>
<journal-title-group>
<journal-title>Cardiologia Croatica</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Cardiol. Croat.</abbrev-journal-title>
</journal-title-group>
<issn pub-type="ppub">1848-543X</issn>
<issn pub-type="epub">1848-5448</issn>
<publisher><publisher-name>Croatian Cardiac Society</publisher-name></publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">CC_12(9-10)_375</article-id>
<article-id pub-id-type="doi">10.15836/ccar2017.375</article-id>
<article-categories><subj-group subj-group-type="heading"><subject>Extended Abstract</subject></subj-group>
</article-categories>
<title-group>
<article-title>Cryoablation decreases platelet reactivity in patients with&#x2028;atrial fibrillation compared with radiofrequency ablation: results from the Sparelife Project</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-9346-6402</contrib-id><name><surname>Samard&#x017E;i&#x0107;</surname><given-names>Jure</given-names></name></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-5425-5840</contrib-id><name><surname>Velagi&#x0107;</surname><given-names>Vedran</given-names></name></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-5979-2346</contrib-id><name><surname>Skori&#x0107;</surname><given-names>Bo&#x0161;ko</given-names></name></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-3705-0226</contrib-id><name><surname>Pavasovi&#x0107;</surname><given-names>Sa&#x0161;a</given-names></name></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-3197-2190</contrib-id><name><surname>Pa&#x0161;ali&#x0107;</surname><given-names>Marijan</given-names></name></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-2599-553X</contrib-id><name><surname>Jurin</surname><given-names>Hrvoje</given-names></name></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-0561-6704</contrib-id><name><surname>Planinc</surname><given-names>Ivo</given-names></name></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-4772-5549</contrib-id><name><surname>&#x010C;ike&#x0161;</surname><given-names>Maja</given-names></name></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-3603-2242</contrib-id><name><surname>Puljevi&#x0107;</surname><given-names>Davor</given-names></name></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-9101-1570</contrib-id><name><surname>Mili&#x010D;i&#x0107;</surname><given-names>Davor</given-names></name></contrib>
<aff id="aff1">University of Zagreb School of Medicine, <institution>University Hospital Centre Zagreb</institution>, <addr-line>Zagreb</addr-line>, <country>Croatia</country></aff>
</contrib-group>
<author-notes>
<corresp id="cor1">Address for correspondence: Jure Samard&#x017E;i&#x0107;, Klini&#x010D;ki bolni&#x010D;ki centar Zagreb, Ki&#x0161;pati&#x0107;eva 12, HR-10000 Zagreb, Croatia. / Phone: +385-98-537-864 / E-mail: <email xlink:href="jure.samardzic@gmail.com">jure.samardzic@gmail.com</email></corresp></author-notes>
<pub-date pub-type="epub-ppub"><month>10</month><year>2017</year></pub-date>
<volume>12</volume>
<issue>9-10</issue>
<fpage>375</fpage>
<lpage>375</lpage>
<history>
<date date-type="received"><day>24</day><month>09</month><year>2017</year></date><date date-type="accepted"><day>26</day><month>09</month><year>2017</year></date>
</history>
<permissions>
<copyright-year>2017</copyright-year>
<copyright-holder>Croatian Cardiac Society</copyright-holder>
</permissions>
<kwd-group kwd-group-type="author"><title>Keywords: </title><kwd>atrial fibrillation</kwd><kwd>pulmonary vein isolation</kwd><kwd>platelet reactivity</kwd></kwd-group>
</article-meta>
</front>
<body>
<p><bold>Introduction</bold>: Pulmonary vein isolation (PVI) procedures increase the potential thromboembolic risk (<xref ref-type="bibr" rid="r1"><italic>1</italic></xref>). The aim of this study was to compare the effect of radiofrequency (RF) ablation and cryoablation on platelet reactivity (PR) in patients with atrial fibrillation (AF).</p>
<p><bold>Patients and Methods</bold>: We analyzed PR levels using Multiplate function analyzer in 63 consecutive patients undergoing PVI procedures in our institution. Blood samples were drawn just before the procedure and on the following day. Fourty six (46) and seventeen (17) patients underwent cryoablation and RF ablation, respectively. There was no difference in demographics and baseline platelet parameters (platelet count, MPV and PR) between patients in RF and cryo group. ASPI, ADP and TRAPtest were used to --assess multiple pathways of platelet activation.</p>
<p><bold>Results</bold>: One day after the procedure mean PR droped from baseline levels in both study groups. The observed delta was more expressed in the cryo group for all three PR tests but only ADPtest showed statistically significant difference in PR (<xref ref-type="fig" rid="f1"><bold>Figure 1</bold></xref>).</p>
<fig id="f1" position="float" fig-type="figure"><label>FIGURE 1</label><caption><p>Platelet reactivity before and after pulmonary vein isolation.&#x2028;RF = radiofrequency</p></caption><graphic xlink:href="CC_12(9-10)_375-f1"></graphic></fig>
<p><bold>Conclusion</bold>: Our results show that PR after cryoablation is less pronounced compared to RF procedure. This affirms that thrombogenic burden of PVI is lower with cryoablation. We hypothesize that this could be a result of endocardial integrity preservation and decreased availability of platelet agonists during cryoablation. These results warrant further investigations with periinterventional PR measurements on a larger cohort of patients.</p>
</body>
<back>
<ack>
<p><bold>Aknowledgement</bold>: This study was funded by Croatian Science Foundation.</p>
</ack>
<ref-list>
<title>LITERATURE</title>
<ref id="r1"><label>1</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tse</surname><given-names>HF</given-names></name><name><surname>Kwong</surname><given-names>YL</given-names></name><name><surname>Lau</surname><given-names>CP</given-names></name></person-group>. <article-title>Transvenous cryoablation reduces platelet activation during pulmonary vein ablation compared with radiofrequency energy in patients with atrial fibrillation.</article-title> <source>J Cardiovasc Electrophysiol</source>. <year>2005</year> Oct;<volume>16</volume>(<issue>10</issue>):<fpage>1064</fpage>&#x2013;<lpage>70</lpage>. <pub-id pub-id-type="doi">10.1111/j.1540-8167.2005.50103.x</pub-id><pub-id pub-id-type="pmid">16191116</pub-id></mixed-citation></ref>
</ref-list>
</back>
</article>
